EUVIMEDEUVIMED entdecken
Crossref

Progestin primed ovarian stimulation using dydrogesterone from day 7 of the cycle onwards in oocyte donation cycles: a longitudinal study

S Hendrickx, M De Vos, N De Munck, S Mackens, S Ruttens, H Tournaye, C Blockeel

Reproductive BioMedicine Online · 2024

DOI: 10.1016/j.rbmo.2023.103732 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproductive BioMedicine Online, 2024. Verfasst von S Hendrickx und 6 weiteren Autor:innen. Beteiligte Einrichtung: Brussels IVF, Universitair Ziekenhuis Brussel, Brussels, Belgium. Electronic address: sophie.hendrickx@uzbrussel.be. Hauptthemen laut MEDLINE: Ovulation Induction, Dydrogesterone, Oocyte Donation, Progestins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RESEARCH QUESTION: Does a progestin-primed ovarian stimulation (PPOS) protocol with dydrogesterone from cycle day 7 yield similar outcomes compared with a gonadotrophin-releasing hormone (GnRH) antagonist protocol in the same oocyte donors? DESIGN: This retrospective longitudinal study included 128 cycles from 64 oocyte donors. All oocyte donors had the same type of gonadotrophin and daily dose in both stimulation cycles. The primary outcome was the number of cumulus-oocyte complexes (COC) retrieved. RESULTS: The number of COC retrieved (mean ± SD 19.7 ± 10.8 versus 19.2 ± 8.3; P = 0.5) and the number of metaphase II oocytes (15.5 ± 8.4 versus 16.2 ± 7.0; P = 0.19) were similar for the PPOS and GnRH antagonist protocols, respectively. The duration of stimulation (10.5 ± 1.5 days versus 10.8 ± 1.5 days; P = 0.14) and consumption of gonadotrophins (2271.9 ± 429.7 IU versus 2321.5 ± 403.4 IU; P = 0.2) were also comparable, without any cases of premature ovulation. Nevertheless, there was a significant difference in the total cost of medication per cycle: €898.3 ± 169.9 for the PPOS protocol versus €1196.4 ± 207.5 (P < 0.001) for the GnRH antagonist protocol. CONCLUSION: The number of oocytes retrieved and number of metaphase II oocytes were comparable in both stimulation protocols, with the advantage of significant cost reduction in favour of the PPOS protocol compared with the GnRH antagonist protocol. No cases of premature ovulation were observed, even when progestin was started later in the stimulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovulation InductionDydrogesteroneOocyte DonationProgestinsGonadotropin-Releasing HormoneHumansFemaleAdultLongitudinal StudiesRetrospective StudiesOocyte RetrievalPregnancy

Stichwörter der Autor:innen

CostDydrogesteroneOocyte donation cycleOocyte donorOvarian stimulationProgestin-primed ovarian stimulation

Substanzen

DydrogesteroneProgestinsGonadotropin-Releasing Hormone

Autor:innen und Institutionen

  • Brussels IVF, Universitair Ziekenhuis Brussel, Brussels, Belgium. Electronic address: sophie.hendrickx@uzbrussel.be.
  • Brussels IVF, Universitair Ziekenhuis Brussel, Brussels, Belgium; Vrije Universiteit Brussel, Brussels, Belgium.
  • Brussels IVF, Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • Brussels IVF, Universitair Ziekenhuis Brussel, Brussels, Belgium; Vrije Universiteit Brussel, Brussels, Belgium; Department of Obstetrics, Gynaecology, Perinatology and Reproduction, Institute of Professional Education,…
  • Brussels IVF, Universitair Ziekenhuis Brussel, Brussels, Belgium; Vrije Universiteit Brussel, Brussels, Belgium; Department of Obstetrics and Gynaecology, School of Medicine, University of Zagreb, Zagreb, Croatia.

Zitieren

APA

Hendrickx, S., De Vos, M., De Munck, N., Mackens, S., Ruttens, S., Tournaye, H., & Blockeel, C. (2024). Progestin primed ovarian stimulation using dydrogesterone from day 7 of the cycle onwards in oocyte donation cycles: a longitudinal study. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2023.103732

Vancouver

Hendrickx S, De Vos M, De Munck N, Mackens S, Ruttens S, Tournaye H, et al. Progestin primed ovarian stimulation using dydrogesterone from day 7 of the cycle onwards in oocyte donation cycles: a longitudinal study. Reproductive BioMedicine Online. 2024. doi:10.1016/j.rbmo.2023.103732

BibTeX
@article{Hendrickx2024,
  author = {Hendrickx, S and De Vos, M and De Munck, N and Mackens, S and Ruttens, S and Tournaye, H and Blockeel, C},
  title = {Progestin primed ovarian stimulation using dydrogesterone from day 7 of the cycle onwards in oocyte donation cycles: a longitudinal study},
  journal = {Reproductive BioMedicine Online},
  year = {2024},
  doi = {10.1016/j.rbmo.2023.103732}
}
Kostenlos starten →